Advertisement

Reactions Weekly

, Volume 1714, Issue 1, pp 61–61 | Cite as

Asunaprevir/daclatasvir

Various toxicities: 4 case reports
Case report
  • 13 Downloads

Reference

  1. Suzuki F, et al. Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in Japan. Hepatology International 12: 244-253, No. 3, May 2018. Available from: URL: http://doi.org/10.1007/s12072-018-9872-z - JapanCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations